Showing results (1381-1390 of 1,395) with videos related to

Sort By:
Pageof 140
European Journal of Preventive Cardiology|December 13, 2016
Genetic invalidation of Lp-PLA<sub>2</sub> as a therapeutic target: Large-scale study of five functional Lp-PLA<sub>2</sub>-lowering allelesJohn M Gregson, Daniel F Freitag, Praveen Surendran, et al.
European Journal of Preventive Cardiology|May 16, 2024
Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regionsSteven H J Hageman, Stephen Kaptoge, Tamar I de Vries, et al.
Nature Communications|March 10, 2015
Genome of The Netherlands population-specific imputations identify an ABCA6 variant associated with cholesterol levelsElisabeth M van Leeuwen, Lennart C Karssen, Joris Deelen, et al.
The New England Journal of Medicine|October 5, 2012
C-reactive protein, fibrinogen, and cardiovascular disease prediction, Stephen Kaptoge, Emanuele Di Angelantonio, et al.
Statistics in Medicine|March 9, 2010
Bayesian methods for meta-analysis of causal relationships estimated using genetic instrumental variablesStephen Burgess, Simon G Thompson, , et al.
Science Translational Medicine|June 3, 2016
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart diseaseRobert A Scott, Daniel F Freitag, Li Li, et al.
Nature Genetics|September 13, 2016
Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertensionPraveen Surendran, Fotios Drenos, Robin Young, et al.
Nature Genetics|November 24, 2020
Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individualsPraveen Surendran, Elena V Feofanova, Najim Lahrouchi, et al.
Pageof 140